NABNEC: A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas

Markman, Ben (Primary Chief Investigator (PCI))
Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Description

NMA Reference Number: HREC/16/HAWKE/26.
SSA Reference Number: SSA/16/MonH/202.
Monash Health HREC Ref: 16284X

Status	Finished
Effective start/end date	12/12/18 → 11/12/23